These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33751883)

  • 21. Eukaryotic microalgae as hosts for light-driven heterologous isoprenoid production.
    Lauersen KJ
    Planta; 2019 Jan; 249(1):155-180. PubMed ID: 30467629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tolerance engineering in bacteria for the production of advanced biofuels and chemicals.
    Mukhopadhyay A
    Trends Microbiol; 2015 Aug; 23(8):498-508. PubMed ID: 26024777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancing isoprenoid production through systematically assembling and modulating efflux pumps in Escherichia coli.
    Wang JF; Xiong ZQ; Li SY; Wang Y
    Appl Microbiol Biotechnol; 2013 Sep; 97(18):8057-67. PubMed ID: 23864262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bacterial membrane transporter systems for aromatic compounds: Regulation, engineering, and biotechnological applications.
    Mutanda I; Sun J; Jiang J; Zhu D
    Biotechnol Adv; 2022 Oct; 59():107952. PubMed ID: 35398204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Engineering endogenous ABC transporter with improving ATP supply and membrane flexibility enhances the secretion of β-carotene in
    Bu X; Lin JY; Cheng J; Yang D; Duan CQ; Koffas M; Yan GL
    Biotechnol Biofuels; 2020; 13():168. PubMed ID: 33062054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Yeast metabolic engineering for the production of pharmaceutically important secondary metabolites.
    Rahmat E; Kang Y
    Appl Microbiol Biotechnol; 2020 Jun; 104(11):4659-4674. PubMed ID: 32270249
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In Vitro Interactions of Epacadostat and its Major Metabolites with Human Efflux and Uptake Transporters: Implications for Pharmacokinetics and Drug Interactions.
    Zhang Q; Zhang Y; Boer J; Shi JG; Hu P; Diamond S; Yeleswaram S
    Drug Metab Dispos; 2017 Jun; 45(6):612-623. PubMed ID: 28283500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Applications and advances of metabolite biosensors for metabolic engineering.
    Liu D; Evans T; Zhang F
    Metab Eng; 2015 Sep; 31():35-43. PubMed ID: 26142692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic engineering of antibiotic factories: new tools for antibiotic production in actinomycetes.
    Weber T; Charusanti P; Musiol-Kroll EM; Jiang X; Tong Y; Kim HU; Lee SY
    Trends Biotechnol; 2015 Jan; 33(1):15-26. PubMed ID: 25497361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux.
    Wall SC; Gu H; Rudnick G
    Mol Pharmacol; 1995 Mar; 47(3):544-50. PubMed ID: 7700252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic engineering approaches for production of biochemicals in food and medicinal plants.
    Wilson SA; Roberts SC
    Curr Opin Biotechnol; 2014 Apr; 26():174-82. PubMed ID: 24556196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microbial methionine transporters and biotechnological applications.
    Mohany NAM; Totti A; Naylor KR; Janovjak H
    Appl Microbiol Biotechnol; 2021 May; 105(10):3919-3929. PubMed ID: 33929594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transporter engineering in microbial cell factories: the ins, the outs, and the in-betweens.
    van der Hoek SA; Borodina I
    Curr Opin Biotechnol; 2020 Dec; 66():186-194. PubMed ID: 32927362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of efflux and uptake transporters in [N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine (GW572016, lapatinib) disposition and drug interactions.
    Polli JW; Humphreys JE; Harmon KA; Castellino S; O'Mara MJ; Olson KL; John-Williams LS; Koch KM; Serabjit-Singh CJ
    Drug Metab Dispos; 2008 Apr; 36(4):695-701. PubMed ID: 18216274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-yield export of a native heterologous protein to the periplasm by the tat translocation pathway in Escherichia coli.
    Matos CF; Branston SD; Albiniak A; Dhanoya A; Freedman RB; Keshavarz-Moore E; Robinson C
    Biotechnol Bioeng; 2012 Oct; 109(10):2533-42. PubMed ID: 22539025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary metabolites from overproducing microbial system using sustainable substrates.
    Srivastava RK; Akhtar N; Verma M; Imandi SB
    Biotechnol Appl Biochem; 2020 Nov; 67(6):852-874. PubMed ID: 32294277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stereoselectivity of chiral drug transport: a focus on enantiomer-transporter interaction.
    Zhou Q; Yu LS; Zeng S
    Drug Metab Rev; 2014 Aug; 46(3):283-90. PubMed ID: 24796860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tailoring cellular metabolism in lactic acid bacteria through metabolic engineering.
    Sharma A; Gupta G; Ahmad T; Kaur B; Hakeem KR
    J Microbiol Methods; 2020 Mar; 170():105862. PubMed ID: 32032637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efflux in fungi: la pièce de résistance.
    Coleman JJ; Mylonakis E
    PLoS Pathog; 2009 Jun; 5(6):e1000486. PubMed ID: 19557154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Engineering microbial biofuel tolerance and export using efflux pumps.
    Dunlop MJ; Dossani ZY; Szmidt HL; Chu HC; Lee TS; Keasling JD; Hadi MZ; Mukhopadhyay A
    Mol Syst Biol; 2011 May; 7():487. PubMed ID: 21556065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.